title: Weighing the options for human epidermal growth factor receptor 2-directed therapy in metastatic breast cancer.
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA nlin@partners.org.
authors.forename: Nancy U
authors.initials: NU
authors.lastname: Lin
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases